Interested in sponsoring an event? Contact advertising@bisnow.com

The Future of Houston Life Sciences & Healthcare Innovation

Name: The Future of Houston Life Sciences & Healthcare Innovation
Start: 2022-02-17T08:00:00-06:00
End: 2022-02-17T11:00:00-06:00
Location: The Westin Galleria Houston

Deep Diving Into The Nations Top Emerging Market

Event Ended On: Thursday February 17 2022

Attendee List Become A Speaker

Registration Questions?
**Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once the ticket prices have been raised.
**Bisnow is a cashless, checkless operation. Please only submit payment via credit card.

OUR COMMITMENT TO YOUR SAFETY

We have experienced the enthusiasm of returning to live in-person events this year, having safely and successfully hosted more than 23,000 executives to date. While we are thrilled to convene together to propel growth within CRE, COVID-19 remains a worldwide concern and Bisnow is committed to practicing safe protocols at our events. You can expect the following:

In accordance with CDC guidelines, we are recommending that all participants wear a mask, regardless of vaccination status. Masks will be made available at the door.
Temperature checks will be conducted at entry.
Contact tracing procedures will be employed for any reported exposure.
Socially distanced seating will be available in the main event space.
Enhanced sanitization protocols will be adhered to throughout the event space including regularly disinfecting surfaces throughout the event and hand sanitizer provided to all attendees.

As local regulations and guidance evolve, the CRE industry continues to lead the way forward. We will gather safely to do what we do best: network, connect, and engage to do more business. We look forward to hosting you soon.

Speakers and Panels

Keynote Presentation TMC President & CEO Bill McKeon

William F. McKeon

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas Medical Center’s member institutions to enhance its leadership position in the life sciences. McKeon joined the Texas Medical Center in 2013 as executive vice president, chief operating officer and chief strategy officer. McKeon attended Roger Williams University on the Harold G. Way Scholarship for Leadership and Academic Excellence. He worked throughout his college years as a legal intern at Asquith, Merolla, Anderson, Ryan & Wiley – a prestigious law firm in Providence, Rhode Island. He graduated with top honors with a Bachelor of Science in Legal Studies. He earned his master’s degree from University of San Francisco School of Management. McKeon began his professional career at Du Pont de Nemours. He initially led the implementation of large news publishing systems around the world and was later promoted to run marketing and business development. During his time at Du Pont, McKeon lived throughout the United States, United Kingdom and Sweden. His career shifted to health care when he was recruited to Stanford University Medical Center, where he initially led the Cardiovascular Medicine and Cardiothoracic Surgery business. He was then promoted to Director of Market Development for all 17 business lines at Stanford. He then went to Raytel Medical Systems - the largest cardiac monitoring business in the United States. He served as Executive Director and digitized all businesses so that physicians could see patients’ EKGs online from anywhere in the world. At Raytel, he won the Computer World Smithsonian Award in Medicine. McKeon came to Houston to join U.S. Oncology, which provides cancer care for over 25 percent of the U.S. population. There, he served as Senior Vice President of Marketing and Pharmaceutical Business Relations. During McKeon’s tenure, U.S. Oncology grew from $250 million to $1.4 billion, filed for IPO and was later acquired by the McKesson Corporation. McKeon then moved to Medtronic Inc., the largest medical device company in the world. He led Strategy and Emerging Technologies across all of the Medtronic businesses. His main focus was to define the digital strategy for all Medtronic medical devices so that they could connect to cellular devices. McKeon was then recruited to serve as President and CEO of Microport Inc. in Shanghai. He grew the business from $17 million to $157 million in two years. Additionally, he diversified the business from one line to four lines and prepared the company for IPO. Today, Microport is listed on the Hong Kong stock exchange. McKeon then moved to London to serve as President and CEO of Cellnovo, the first mobile diabetes management system in the world. He raised $10 million for its Series A round and $57 million for the Series B. Cellnovo is public on the European Exchange.

Texas Medical Center

President & CEO

William F. McKeon

President & CEO, Texas Medical Center

Opening Remarks With The Greater Houston Partnership

Life Science Update With Torrey Adams

Torrey Adams

Senior Director, Global Life Sciences, Greater Houston Partnership

The Keys To Creating A National Life Science Hub

How To Successfully Compete With Other Well-Established Clusters in the U.S.

Shawn Cloonan

Life Sciences Lead & General Counsel, McCord Development

Justin Brasell

EMD, Transwestern

Craig Laher

SVP & Head of Healthcare & Life Sciences, The Signorelli Company

Tim O'Connell

Senior Principal and Director, Science + Technology, HOK

Jose Rivera

Central Region Life Science Leader, DPR Construction

Moderator

Martin Togni

Partner, Allen Matkins

Fostering Innovation & Technology In A Rapidly Changing Industry

Technology and Innovations Role In The Future of Life Sciences & Healthcare

Papia Ghosh

Manager, Office of Technology Commercialization, MD Anderson Cancer Center

John Schultz

Director, Office of Technology Transfer, Houston Methodist Hospital and Research Institute

Fiona Mack

Head of JLABS, TMC

Tom Luby

Director, Texas Medical Center (TMC) Innovation.

Jan Odegard

Executive Director, The Ion

Moderator

Richard Barbles

Director, Newmark

Venue

The Westin Galleria Houston
5060 W Alabama St.
Houston, TX 77056

Ballroom: Woodway I & foyer

Parking Information:

Parking information: For free parking, utilize the Brown Garage which will lead you directly to the lobby of the hotel. Valet is also available for $25+tax.

Get Directions

Agenda

Time	Activity
8:00 AM 8:50 AM	Opening Networking
8:50 AM 9:00 AM	Opening Remarks With The Greater Houston Partnership Life Science Update With Torrey Adams
9:00 AM 9:15 AM	Keynote Presentation With President & CEO of the Texas Medical Center Bill McKeon
9:15 AM 10:00 AM	The Keys To Creating A National Life Science Hub How To Successfully Compete With Other Well-Established Clusters in the U.S.
10:00 AM 10:50 AM	Fostering Innovation & Technology In A Rapidly Changing Industry The Future of Life Sciences & Healthcare Innovation
10:50 AM 11:15 AM	Closing Networking

Why This Matters

What You'll Learn:

What are the next steps for Houston to become a national life sciences hub, rivaling the national coastal centers and international leaders?
How are emerging industries in Houston, such as nanotechnology, biodefense and stem cell research, changing the area's ecosystem?
Incubators are essential to anchoring tenants to a market. What are investors doing to further invest in expanding the Greater Houston Area?
How integral are educational systems, like UT, A&M, and Rice and their advanced young talent, in strengthening Houston's potential and success in the research domain?
What effect do major research developments like Ion Tower, Innovation Plaza, and the incredible TMC3 have on Houston's world stage potential?
What are some of the new and emerging technologies that will impact the industry in the years to come?
How do industry leaders draw the attention of investors and tenants from the coastal hubs inland toward Texas and Houston?

How You'll Do More Business: Houston's reputation as a life sciences hub is growing. With current projects like Texas A&M's Innovation Plaza and the largest life sciences building in the world, TMC3, Houston is primed and ready to rival national and international leaders in life sciences. Factors like the local young talent pool and the long-term potential to achieve market maturity are attracting life sciences companies, owners and developers to the area. However, the city still lacks enough lab space to seriously compete with other well-established clusters in the U.S. While there are several projects in the pipeline, that does not address the more immediate problem of catering to startups and companies that need space right now. Join us as we address these topics and so much more at our first ever in-person life sciences event. Learn what 2022 holds for Houston's future and how market leaders are working to achieve a world-class status.

Who You’ll Meet: GC's, Architects, Developers, Owners, Investors, Engineers, and Lawyers

What Does Your Ticket Get You: Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us.

Questions about your ticket purchase or interested in sponsoring? Reach out to customerservice@bisnow.com for customer support.

For questions, recommendations, comments or press inquiries please email our Texas event producer Sophie McCourt at sophie.mccourt@bisnow.com